Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reto Brun

Showing results (391-400 of 399) with videos related to

Pageof 40
Sort By:
You have reached the last page of results.This site can display upto 399 results.
The Journal of Biological Chemistry|June 12, 2013
UV-triggered affinity capture identifies interactions between the Plasmodium falciparum multidrug resistance protein 1 (PfMDR1) and antimalarial agents in live parasitized cellsRalf Brunner, Caroline L Ng, Hamed Aissaoui, et al.
Plos Neglected Tropical Diseases|July 9, 2011
SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasisRobert T Jacobs, Bakela Nare, Stephen A Wring, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malariaSusan A Charman, Sarah Arbe-Barnes, Ian C Bathurst, et al.
Journal of Medicinal Chemistry|April 25, 2012
Imidazolopiperazines: lead optimization of the second-generation antimalarial agentsAdvait Nagle, Tao Wu, Kelli Kuhen, et al.
Journal of Medicinal Chemistry|March 18, 2022
Repositioning of a Diaminothiazole Series Confirmed to Target the Cyclin-Dependent Kinase CRK12 for Use in the Treatment of African Animal TrypanosomiasisAlasdair Smith, Richard J Wall, Stephen Patterson, et al.
Science (New York, N.Y.)|September 4, 2010
Spiroindolones, a potent compound class for the treatment of malariaMatthias Rottmann, Case McNamara, Bryan K S Yeung, et al.
Chemmedchem|July 30, 2016
Discovery and Characterization of ACT-451840: an Antimalarial Drug with a Novel Mechanism of ActionChristoph Boss, Hamed Aissaoui, Nathalie Amaral, et al.
Journal of Medicinal Chemistry|June 8, 2011
Imidazolopiperazines: hit to lead optimization of new antimalarial agentsTao Wu, Advait Nagle, Kelli Kuhen, et al.
Plos Medicine|October 5, 2016
Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy ModelingAmélie Le Bihan, Ruben de Kanter, Iñigo Angulo-Barturen, et al.
Pageof 40

Showing results (391-400 of 399) with videos related to

Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 399 results.
The Journal of Biological Chemistry|June 12, 2013
UV-triggered affinity capture identifies interactions between the Plasmodium falciparum multidrug resistance protein 1 (PfMDR1) and antimalarial agents in live parasitized cellsRalf Brunner, Caroline L Ng, Hamed Aissaoui, et al.
Plos Neglected Tropical Diseases|July 9, 2011
SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasisRobert T Jacobs, Bakela Nare, Stephen A Wring, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malariaSusan A Charman, Sarah Arbe-Barnes, Ian C Bathurst, et al.
Journal of Medicinal Chemistry|April 25, 2012
Imidazolopiperazines: lead optimization of the second-generation antimalarial agentsAdvait Nagle, Tao Wu, Kelli Kuhen, et al.
Journal of Medicinal Chemistry|March 18, 2022
Repositioning of a Diaminothiazole Series Confirmed to Target the Cyclin-Dependent Kinase CRK12 for Use in the Treatment of African Animal TrypanosomiasisAlasdair Smith, Richard J Wall, Stephen Patterson, et al.
Science (New York, N.Y.)|September 4, 2010
Spiroindolones, a potent compound class for the treatment of malariaMatthias Rottmann, Case McNamara, Bryan K S Yeung, et al.
Chemmedchem|July 30, 2016
Discovery and Characterization of ACT-451840: an Antimalarial Drug with a Novel Mechanism of ActionChristoph Boss, Hamed Aissaoui, Nathalie Amaral, et al.
Journal of Medicinal Chemistry|June 8, 2011
Imidazolopiperazines: hit to lead optimization of new antimalarial agentsTao Wu, Advait Nagle, Kelli Kuhen, et al.
Plos Medicine|October 5, 2016
Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy ModelingAmélie Le Bihan, Ruben de Kanter, Iñigo Angulo-Barturen, et al.
Pageof 40